TECX vs TER · $567.2M cap vs P/E 76, rev $2.82B
Tectonic Therapeutic, Inc. (TECX) versus Teradyne Inc (TER) — a side-by-side from cached financials, not a winner call.
Tectonic Therapeutic, Inc. (TECX) is a biotechnology company listed on NASDAQ.
Teradyne Inc (TER) is a semiconductor equipment & materials company listed on NASDAQ.
TECX does not have a complete income-statement cache yet.
Latest reported TER revenue for 2024-12-31 was $2.82B. Net income was $542.4M. Revenue was up 5.4% from 2023-12-31 to 2024-12-31. TER currently screens at market cap $63.96B and trailing P/E 75.7.
TECX currently screens at market cap $567.2M. TER currently screens at market cap $63.96B and trailing P/E 75.7.
Not investment advice. Open the TECX and TER stock pages for the full models.
Not investment advice.